A Senthinathan, V Kelly, M Dzingina, D Jones, M Baker, D Longson et al
Senthinathan A, Kelly V, Dzingina M, Jones D, Baker M, Longson D et al.
Hyperglycaemia in acute coronary syndromes: summary of NICE guidance
BMJ 2011; 343 :d6646
doi:10.1136/bmj.d6646
Hyperglycaemia in acute coronary syndromes
The NICE guidelines quoted in this article suggest a range of
investigations to identify patients with hypergylcaemia who are at risk of
developing diabetes after acute coronary syndromes. This includes HB A1C
and fasting blood glucose at no less than 4 days post event. Advice on
lifestyle and further follow-up is also recommended. Throughout the
country there has been increasing uptake of primary percutaneous coronary
intervention for acute ST elevation myocardial infarction. In
uncomplicated cases discharge may be just 48 to 72 hours after presenting
to hospital. Therefore this group of patients may not be optimally
managed/investigated from a diabetic perspective. It would be important to
make sure cardiac rehabilitation services who make contact with patients
in the few weeks post-MI incorporate these guidelines into their pro-
active risk factor reduction programmes.
Competing interests: No competing interests